Weekly Research Analysts’ Ratings Updates for CVS Health (CVS)

CVS Health (NYSE: CVS) has recently received a number of price target changes and ratings updates:

• 2/12/2025 – CVS Health was upgraded by analysts at Cantor Fitzgerald from a “neutral” rating to an “overweight” rating.
• 2/11/2025 – CVS Health had its price target raised by analysts at Wolfe Research from 67.00 to 70.00. They now have an “overweight” rating on the stock.
• 2/11/2025 – CVS Health had its price target lowered by analysts at UBS Group AG from $62.00 to $59.00. They now have a “neutral” rating on the stock.
• 2/11/2025 – CVS Health had its price target raised by analysts at Leerink Partners from $51.00 to $55.00. They now have a “market perform” rating on the stock.
• 1/30/2025 – CVS Health was upgraded by analysts at Edward Jones from a “hold” rating to a “buy” rating.
• 1/27/2025 – CVS Health had its price target raised by analysts at Evercore ISI from $60.00 to $65.00. They now have an “outperform” rating on the stock.
• 1/6/2025 – CVS Health had its price target lowered by analysts at Truist Financial Co. from $67.00 to $60.00. They now have a “buy” rating on the stock.

CVS Health Price Performance

CVS stock opened at $63.23 on Thursday. The stock’s 50 day moving average is $50.61 and its two-hundred day moving average is $55.92. CVS Health Co. has a 52-week low of $43.56 and a 52-week high of $80.75. The company has a market capitalization of $79.57 billion, a PE ratio of 16.05, a P/E/G ratio of 0.60 and a beta of 0.61. The company has a quick ratio of 0.59, a current ratio of 0.80 and a debt-to-equity ratio of 0.80.

CVS Health (NYSE:CVS) last posted its quarterly earnings results on Wednesday, February 12th. The pharmacy operator reported $1.19 EPS for the quarter, topping analysts’ consensus estimates of $0.89 by $0.30. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. Analysts predict that CVS Health Co. will post 5.14 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Monday, February 3rd. Shareholders of record on Thursday, January 23rd were issued a dividend of $0.665 per share. The ex-dividend date of this dividend was Thursday, January 23rd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.21%. CVS Health’s dividend payout ratio (DPR) is 67.51%.

Hedge Funds Weigh In On CVS Health

A number of large investors have recently bought and sold shares of the business. Norges Bank acquired a new stake in shares of CVS Health in the 4th quarter worth about $839,574,000. Davis Selected Advisers grew its position in CVS Health by 2,998.1% in the 4th quarter. Davis Selected Advisers now owns 11,385,950 shares of the pharmacy operator’s stock worth $511,115,000 after purchasing an additional 11,018,438 shares during the last quarter. Pzena Investment Management LLC increased its stake in shares of CVS Health by 49.3% in the fourth quarter. Pzena Investment Management LLC now owns 19,610,579 shares of the pharmacy operator’s stock valued at $880,319,000 after purchasing an additional 6,475,271 shares during the period. Hotchkis & Wiley Capital Management LLC raised its holdings in shares of CVS Health by 34.8% during the third quarter. Hotchkis & Wiley Capital Management LLC now owns 11,897,034 shares of the pharmacy operator’s stock valued at $748,085,000 after buying an additional 3,071,613 shares during the last quarter. Finally, Raymond James Financial Inc. acquired a new position in shares of CVS Health during the fourth quarter worth approximately $116,033,000. Institutional investors own 80.66% of the company’s stock.

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.